View Cart (0 items)

Items Tagged with 'Mergers & acquisitions'

ARTICLES

Post Holdings to acquire MOM Brands for $1.15 billion

Post Holdings has entered into a definitive agreement to acquire MOM Brands, maker of branded ready-to-eat and natural cereals, hot wheat and oatmeal, for approximately $1.15 billion.
Read More

Australia's Cardia Bioplastics, Stellar films agree to merger terms

Australian manufacturers Cardia Bioplastics Limited and Stellar Films Group have entered into a merger agreement, building on the existing cooperation between the two firms. Plans for the merger were first unveiled in late November 2014.
Read More

Solvay acquires Ryton polyphenylene sulfide business

Global chemical company Solvay has completed the acquisition of the Ryton® PPS (polyphenylene sulphide) business from U.S.-based Chevron Phillips Chemical Company for $220 million.
Read More

Shire agrees to acquire NPS Pharma for $5.2 billion

British pharmaceutical company Shire plc has agreed to acquire U.S.-based NPS Pharma for $5.2 billion, strengthening its capabilities in treating rare diseases and gastrointestinal disorders.
Read More

Lubrizol closes acquisition of Warwick Chemicals, Weatherford businesses

Chemicals company The Lubrizol Corporation has completed two acquisitions within the space of one week, expanding its home care operations and creating a new business segment in the field of oilfield solutions.
Read More

Coatings maker Hempel makes another acquisition

Global coatings specialist Hempel has expanded its business with the acquisition of Dutch coatings manufacturer Schaepman, and said it will benefit from Schaepman's proven expertise in protective coatings.
Read More

BioMarin to acquire DMD drug developer Prosensa

Biopharmaceuticals company BioMarin Pharmaceutical Inc. revealed on Monday that it has agreed to acquire Prosensa Holding N.V., a drug developer with a focus on rare neuromuscular and neurodegenerative disorders.
Read More

Merck agrees to $8.4 billion deal for antibiotics developer Cubist

Healthcare giant Merck & Co., Inc. is to acquire antibiotics specialist Cubist Pharmaceuticals, Inc. for $8.4 billion, the company announced on Monday.
Read More

Japan's Otsuka to acquire Avanir Pharmaceuticals for $3.5 billion

The Japanese company said on Tuesday that this acquisition would strengthen its business in the area of neurological conditions.
Read More

Allergan enters acquisition deal with Actavis

Botox maker Allergan, Inc. will be acquired by Actavis plc for $66 billion after fending off a hostile takeover bid by activist investor William Ackman and Valeant Pharmaceuticals International Inc.
Read More